Details for New Drug Application (NDA): 207135
✉ Email this page to a colleague
The generic ingredient in OLMESARTAN MEDOXOMIL is amlodipine besylate; hydrochlorothiazide; olmesartan medoxomil. There are fifty drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the amlodipine besylate; hydrochlorothiazide; olmesartan medoxomil profile page.
Summary for 207135
Tradename: | OLMESARTAN MEDOXOMIL |
Applicant: | Umedica |
Ingredient: | olmesartan medoxomil |
Patents: | 0 |
Pharmacology for NDA: 207135
Mechanism of Action | Angiotensin 2 Receptor Antagonists |
Medical Subject Heading (MeSH) Categories for 207135
Suppliers and Packaging for NDA: 207135
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
OLMESARTAN MEDOXOMIL | olmesartan medoxomil | TABLET;ORAL | 207135 | ANDA | Lifestar Pharma LLC | 70756-808 | 70756-808-30 | 30 TABLET in 1 BOTTLE (70756-808-30) |
OLMESARTAN MEDOXOMIL | olmesartan medoxomil | TABLET;ORAL | 207135 | ANDA | Lifestar Pharma LLC | 70756-808 | 70756-808-90 | 90 TABLET in 1 BOTTLE (70756-808-90) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
Approval Date: | Jul 18, 2019 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 20MG | ||||
Approval Date: | Jul 18, 2019 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 40MG | ||||
Approval Date: | Jul 18, 2019 | TE: | AB | RLD: | No |
Complete Access Available with Subscription